article_metadata: Zahra Sadouki Emmanuel Q Wey Satheesh Iype David Nasralla Jonathan Potts Mike Spiro Alan Williams Timothy D McHugh Frank Kloprogge
article_metadata: 10.1111/tid.14396
article_metadata: Transpl Infect Dis
article_metadata: 2025 Jan-Feb;27(1):e14396.
article_metadata: escherichia coli xdr aztreonam ceftazidime‐avibactam hollow fiber infection model personalized medicine
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/39494754/
article_metadata: Anti-Bacterial Agents / administration & dosage Anti-Bacterial Agents / therapeutic use Antibiotic Prophylaxis / methods Aztreonam / administration & dosage Aztreonam / pharmacology Aztreonam / therapeutic use Ceftazidime / administration & dosage Ceftazidime / pharmacology Ceftazidime / therapeutic use Drug Combinations Drug Resistance, Multiple, Bacterial Escherichia coli Infections / drug therapy Escherichia coli Infections / microbiology Escherichia coli Infections / prevention & control Escherichia coli / drug effects Escherichia coli / isolation & purification Liver Transplantation / adverse effects
article_metadata: Anti-Bacterial Agents / administration & dosage Anti-Bacterial Agents / therapeutic use Antibiotic Prophylaxis / methods Aztreonam / administration & dosage Aztreonam / pharmacology Aztreonam / therapeutic use Ceftazidime / administration & dosage Ceftazidime / pharmacology Ceftazidime / therapeutic use Drug Combinations Drug Resistance, Multiple, Bacterial Escherichia coli Infections / drug therapy Escherichia coli Infections / microbiology Escherichia coli Infections / prevention & control Escherichia coli / drug effects Escherichia coli / isolation & purification Liver Transplantation / adverse effects Case Reports Azabicyclo Compounds Humans Male Microbial Sensitivity Tests Middle Aged Precision Medicine Anti-Bacterial Agents Drug Combinations avibactam, ceftazidime drug combination Aztreonam Ceftazidime Azabicyclo Compounds
article_metadata: PMC11827718
article_metadata: 39494754
article_metadata: Personalized CZA-ATM dosing against an XDR E. coli in liver transplant patients; the application of the in vitro hollow fiber system
article_metadata: 2025